Erlotinib (Tarceva) as a Single Agent or Intercalated With Combination Chemotherapy in Patients With EGFR Positive NSCLC

PHASE2CompletedINTERVENTIONAL
Enrollment

143

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

March 31, 2009

Study Completion Date

March 31, 2009

Conditions
Carcinoma, Non-Small-Cell Lung
Interventions
DRUG

Tarceva

oral tablet

DRUG

carboplatin

IV

DRUG

paclitaxel

IV

Trial Locations (43)

17901

Pottsville Cancer Clinic, Pottsville

19111

Fox Chase Cancer Center, Philadelphia

23320

Cancer Specialists of Tidewater, Ltd., Chesapeake

30045

Suburban Hematology-Oncology Associates, Lawrenceville

31201

Central Georgia Cancer Care, P.C., Macon

32806

MD Anderson Cancer Ctr - Orlando, Orlando

33614

Gulfcoast Oncology Associates, Tampa

38104

Boston Baskin Cancer Groupd/b/a U. of Tennessee Cancer Inst., Memphis

38120

The West Cancer Clinic, Memphis

38138

ACORN, Memphis

40202

Norton Healthcare, Inc., Louisville

48201

Karmanos Cancer Institute, Detroit

55455

Univ. of Minnesota Cancer Center, Minneapolis

59101

Hematology Oncology Centers of Northern Rockies Research, Billings

60612

Rush-Presbyterian-St.Luke's Med Ctr, Chicago

60637

University of Chicago Medical Center, Chicago

68124

Alegent Healthcare, Omaha

77030

University of Texas M.D. Anderson Cancer Center, Houston

80045

University of Colorado Cancer Center, Aurora

80218

Rocky Mountain Cancer CenterResearch Department, Denver

89052

Comprehensive Cancer Centers of Nevada, Henderson

90277

Cancer Care Associates Medical Group, Inc., Redondo Beach

91325

North Valley Hematology/Oncology Medical GroupThe Thomas and Dorothy Leavey Cancer Center, Northridge

91767

Wilshire Oncology Medical GroupThe Robert and Beverly Lewis Family Cancer Care Center, Pomona

91801

Central Hematology Oncology Medical Group Inc., Alhambra

92835

Virginia K. Crosson Cancer Center, Fullerton

93030

Ventura County Hematology-Oncology Specialists, Oxnard

93105

Sansum Santa Barbara Medical Foundation Clinic, Santa Barbara

Santa Barbara Hematology Oncology Medical Group, Inc., Santa Barbara

93309

Comprehensive Blood and Cancer Center(Part of TORI network), Bakersfield

94520

Bay Area Cancer Research Group, Concord

97213

Providence Portland Medical Center, Portland

98109

Fred Hutchinson Cancer Research Center, Seattle

90813-3244

Pacific Shores Medical Group, Long Beach

90095-7077

UCLA Medical Center, Los Angeles

06360-2910

Eastern Connecticut Hematology and Oncology Associates, Norwich

08060

Hematology-Oncology Associates, SJ, PA - Virtua Health, Mount Holly

05401

Fletcher Allen Health Care, Burlington

B9 5SS

Birmingham Heartlands Hospital, Birmingham

CB2 2RE

CR UK, Cambridge

PE3 6DA

Peterborough District Hospital, Cambridge

G11 6NT

Beatson Oncology Centre, Glasgow

HA6 2RN

Mount Vernon Hospital, Middlesex

Sponsors
All Listed Sponsors
lead

OSI Pharmaceuticals

INDUSTRY

NCT00294762 - Erlotinib (Tarceva) as a Single Agent or Intercalated With Combination Chemotherapy in Patients With EGFR Positive NSCLC | Biotech Hunter | Biotech Hunter